Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chrysoula Pappa, MD
Seaview Jacksonville, LLC
Principal Investigator - Lydie Hazan, MD
Axis Clinical Trials
Principal Investigator - William M Schnitz, MD
Lynn Health Science Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pharmaceutical Research Associates Group B.V.
Zuidlaren, Netherlands
- Axis Clinical Trials
Los Angeles, California, United States
- Seaview Jacksonville, Llc
Jacksonville, Florida, United States
- Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
- Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 16 Nov 2015
- Registered enrollment
- 20
- Registry id
- NCT01357759
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.